281 related articles for article (PubMed ID: 15054086)
1. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
Sidhu A; Wersinger C; Vernier P
FASEB J; 2004 Apr; 18(6):637-47. PubMed ID: 15054086
[TBL] [Abstract][Full Text] [Related]
2. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
Sidhu A; Wersinger C; Vernier P
FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
[TBL] [Abstract][Full Text] [Related]
3. The role of alpha-synuclein in both neuroprotection and neurodegeneration.
Sidhu A; Wersinger C; Moussa CE; Vernier P
Ann N Y Acad Sci; 2004 Dec; 1035():250-70. PubMed ID: 15681812
[TBL] [Abstract][Full Text] [Related]
4. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.
Conway KA; Rochet JC; Bieganski RM; Lansbury PT
Science; 2001 Nov; 294(5545):1346-9. PubMed ID: 11701929
[TBL] [Abstract][Full Text] [Related]
5. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A
J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476
[TBL] [Abstract][Full Text] [Related]
6. Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress.
Wersinger C; Prou D; Vernier P; Sidhu A
FASEB J; 2003 Nov; 17(14):2151-3. PubMed ID: 12958153
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
Lotharius J; Brundin P
Nat Rev Neurosci; 2002 Dec; 3(12):932-42. PubMed ID: 12461550
[No Abstract] [Full Text] [Related]
8. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Richfield EK; Thiruchelvam MJ; Cory-Slechta DA; Wuertzer C; Gainetdinov RR; Caron MG; Di Monte DA; Federoff HJ
Exp Neurol; 2002 May; 175(1):35-48. PubMed ID: 12009758
[TBL] [Abstract][Full Text] [Related]
9. Could a loss of alpha-synuclein function put dopaminergic neurons at risk?
Perez RG; Hastings TG
J Neurochem; 2004 Jun; 89(6):1318-24. PubMed ID: 15189334
[TBL] [Abstract][Full Text] [Related]
10. Synucleins in synaptic plasticity and neurodegenerative disorders.
Clayton DF; George JM
J Neurosci Res; 1999 Oct; 58(1):120-9. PubMed ID: 10491577
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
Dong Z; Ferger B; Feldon J; Büeler H
J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
[TBL] [Abstract][Full Text] [Related]
12. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
Wersinger C; Vernier P; Sidhu A
Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein and Parkinson's disease.
Recchia A; Debetto P; Negro A; Guidolin D; Skaper SD; Giusti P
FASEB J; 2004 Apr; 18(6):617-26. PubMed ID: 15054084
[TBL] [Abstract][Full Text] [Related]
14. A Drosophila model of Parkinson's disease.
Feany MB; Bender WW
Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein and presynaptic function: implications for Parkinson's disease.
Lykkebo S; Jensen PH
Neuromolecular Med; 2002; 2(2):115-29. PubMed ID: 12428807
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.
Xu J; Kao SY; Lee FJ; Song W; Jin LW; Yankner BA
Nat Med; 2002 Jun; 8(6):600-6. PubMed ID: 12042811
[TBL] [Abstract][Full Text] [Related]
17. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons.
Ulusoy A; Björklund T; Buck K; Kirik D
Neurobiol Dis; 2012 Sep; 47(3):367-77. PubMed ID: 22659302
[TBL] [Abstract][Full Text] [Related]
19. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
Lotharius J; Brundin P
Hum Mol Genet; 2002 Oct; 11(20):2395-407. PubMed ID: 12351575
[TBL] [Abstract][Full Text] [Related]
20. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.
Chandra S; Fornai F; Kwon HB; Yazdani U; Atasoy D; Liu X; Hammer RE; Battaglia G; German DC; Castillo PE; Südhof TC
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14966-71. PubMed ID: 15465911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
